Literature DB >> 33398599

The roles of histone deacetylases in kidney development and disease.

Hongbing Liu1.   

Abstract

Histone deacetylases (HDACs) are important epigenetic regulators that mediate deacetylation of both histone and non-histone proteins. HDACs, especially class I HDACs, are highly expressed in developing kidney and subject to developmental control. HDACs play an important role in kidney formation, especial nephron progenitor maintenance and differentiation. Several lines of evidence support the critical role of HDACs in the development and progression of various kidney diseases. HDAC inhibitors (HDACis) are very effective in the prevention and treatment of kidney diseases (including kidney cancer). A better understanting of the molecular mechanisms underlying the role(s) of HDACs in the pathogenesis and progression of renal disease are likely to be of great help in developing more effective and less toxic selective HDAC inhibitors and combinatorial therapeutics.

Entities:  

Keywords:  Histone deacetylase inhibitors; Histone deacetylases; Kidney cancer; Kidney disease

Year:  2021        PMID: 33398599      PMCID: PMC7925501          DOI: 10.1007/s10157-020-01995-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  58 in total

Review 1.  Histone acetylation and disease.

Authors:  S Timmermann; H Lehrmann; A Polesskaya; A Harel-Bellan
Journal:  Cell Mol Life Sci       Date:  2001-05       Impact factor: 9.261

Review 2.  Epigenetics and the environment: emerging patterns and implications.

Authors:  Robert Feil; Mario F Fraga
Journal:  Nat Rev Genet       Date:  2012-01-04       Impact factor: 53.242

Review 3.  Influence of environmental exposure on human epigenetic regulation.

Authors:  Carmen J Marsit
Journal:  J Exp Biol       Date:  2015-01-01       Impact factor: 3.312

Review 4.  Epigenetics: a new way to look at kidney diseases.

Authors:  Pazit Beckerman; Yi-An Ko; Katalin Susztak
Journal:  Nephrol Dial Transplant       Date:  2014-03-27       Impact factor: 5.992

Review 5.  Clinical epigenetics: seizing opportunities for translation.

Authors:  María Berdasco; Manel Esteller
Journal:  Nat Rev Genet       Date:  2019-02       Impact factor: 53.242

Review 6.  Epigenetic regulation of renal development.

Authors:  Samir S El-Dahr; Zubaida Saifudeen
Journal:  Semin Cell Dev Biol       Date:  2018-09-05       Impact factor: 7.727

Review 7.  Renal abnormalities and their developmental origin.

Authors:  Andreas Schedl
Journal:  Nat Rev Genet       Date:  2007-10       Impact factor: 53.242

Review 8.  Epigenetics of kidney disease.

Authors:  Nicola Wanner; Wibke Bechtel-Walz
Journal:  Cell Tissue Res       Date:  2017-03-13       Impact factor: 5.249

Review 9.  Epigenetics in human disease and prospects for epigenetic therapy.

Authors:  Gerda Egger; Gangning Liang; Ana Aparicio; Peter A Jones
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

10.  Prepubertal skeletal muscle growth requires Pax7-expressing satellite cell-derived myonuclear contribution.

Authors:  John F Bachman; Alanna Klose; Wenxuan Liu; Nicole D Paris; Roméo S Blanc; Melissa Schmalz; Emma Knapp; Joe V Chakkalakal
Journal:  Development       Date:  2018-10-25       Impact factor: 6.868

View more
  3 in total

Review 1.  The FOXO family of transcription factors: key molecular players in gastric cancer.

Authors:  Ying Liu; Xiang Ao; Yi Jia; Xiaoge Li; Yu Wang; Jianxun Wang
Journal:  J Mol Med (Berl)       Date:  2022-06-10       Impact factor: 5.606

2.  Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation.

Authors:  Jialu Li; Chao Yu; Fengchen Shen; Binbin Cui; Na Liu; Shougang Zhuang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 3.  Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression.

Authors:  Jiayu Wang; Jiaxing Li; Xin Zhang; Min Zhang; Xiaopeng Hu; Hang Yin
Journal:  Front Mol Biosci       Date:  2022-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.